-
Signature
-
/s/ Sarah Dale, Attorney-in-Fact for Amy Weaver
-
Issuer symbol
-
CRM
-
Transactions as of
-
11 Sep 2023
-
Transactions value $
-
-$1,130,070
-
Form type
-
4
-
Filing time
-
12 Sep 2023, 17:57:38 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
CRM |
Common Stock |
Options Exercise |
$1,771,685 |
+11,494 |
+32.28% |
$154.14 |
47,105 |
11 Sep 2023 |
Direct |
F1 |
| transaction |
CRM |
Common Stock |
Options Exercise |
$772,454 |
+4,783 |
+10.15% |
$161.5 |
51,888 |
11 Sep 2023 |
Direct |
F1 |
| transaction |
CRM |
Common Stock |
Sale |
-$3,459,159 |
-15,327 |
-29.54% |
$225.69 |
36,561 |
11 Sep 2023 |
Direct |
F1, F2 |
| transaction |
CRM |
Common Stock |
Sale |
-$215,049 |
-950 |
-2.6% |
$226.37 |
35,611 |
11 Sep 2023 |
Direct |
F1, F3 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
CRM |
Non-qualified Stock Option (Right to Buy) |
Options Exercise |
$0 |
-11,494 |
-35.35% |
$0 |
21,019 |
11 Sep 2023 |
Common Stock |
11,494 |
$154.14 |
Direct |
F1, F4 |
| transaction |
CRM |
Non-qualified Stock Option (Right to Buy) |
Options Exercise |
$0 |
-4,783 |
-100% |
$0* |
0 |
11 Sep 2023 |
Common Stock |
4,783 |
$161.5 |
Direct |
F1, F5 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: